KEY POINTS FROM THE GUIDELINE
| • An ICS is the cornerstone of asthma control therapy. |
| • For patients 12 years and older or people of any age with asthma uncontrolled by an ICS alone, a combination of an ICS with a rapid-onset LABA (eg, formoterol) should be considered for symptom prevention and relief of acute symptoms. |
| • In patients with uncontrolled asthma on a medium- or high-dose ICS and a LABA, a long-acting muscarinic antagonist should be added. |
| • In patients with well-controlled asthma who are appropriate candidates for therapy de-escalation, the ICS dose should be reduced gradually by 25% to 50% every 3 months. |
Asthma is commonly seen in the primary care setting, and the diagnosis is challenging due to its variable presentation. The 2022 National Health Interview Survey found that approximately 20 million adults and 5 million children in the United States were diagnosed with asthma. Among adults, approximately 13 million were White, 4.5 million were Hispanic/Mexican, and 3 million were Black. Among children, approximately 2 million were White, 1 million were Hispanic, and almost 1 million were Black. Asthma was found to be 10 times more prevalent in women than men.
The US Department of Veterans Affairs and US Department of Defense (VA/DoD) have updated their clinical practice guidelines for managing asthma in patients 5 years and older, with updated pharmacotherapy strategies targeted to patients 12 years and older. The working group evaluated evidence using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system and conducted a systematic literature review including randomized controlled trials and systematic reviews of randomized controlled trials from 2018 to 2024.
GUIDELINE SUMMARY
Assessment and Diagnosis
Assessment. Asthma should be considered in adults presenting with chronic recurring cough, wheezing, chest tightness, or shortness of breath. In children, symptoms include daytime, nighttime, or recurring cough for more than 2 weeks, wheezing, chest tightness, shortness of breath, irritability, and fatigue.
Patients should be asked about day- and nighttime symptoms and precipitating triggers, such as exercise, allergies, cold air, and laughter. Risk factors for asthma include overweight or obesity, atopy, secondhand smoke exposure in childhood, current smoking, occupational exposure, deployment in military personnel, and history of lower respiratory tract infection. Effects on quality of life, sleep, and performance at work or school should be considered, and health and educational needs assessed.
Diagnosis. Asthma is a clinical diagnosis, although diagnostic studies can be used to support the diagnosis. Spirometry should be considered if available and the patient is able to undergo testing. If an obstructive defect is present, bronchodilator testing should be performed to evaluate bronchospasm reversibility. If asthma is suspected despite an inconclusive spirometry result, a bronchoprovocation test should be considered.
Education and Self-Management Support
Physicians should educate patients on the pathophysiology of asthma, symptoms, their specific patterns and triggers, treatment goals, and how to identify well-controlled asthma. A written asthma action plan should be provided to patients, including instruction on use of medications and proper device technique.
Read the full article
Get immediate access, anytime, anywhere.
Choose a single article, issue, or full-access subscription.
Earn up to 14 CME credits per issue.
